Genetic Analysis of Potential Biomarkers and Therapeutic Targets in Neuroinflammation from Sporadic Creutzfeldt-Jakob Disease

Overview

Journal Sci Rep

Specialty Science

Date 2023 Aug 29

PMID 37644077

Authors

Yajing Cheng

Ting Chen

Jun Hu

Affiliations

Soon will be listed here.

Abstract

This study aimed to identify hub genes and pathological mechanisms related to neuroinflammation in Sporadic Creutzfeldt-Jakob disease (SCJD) based on comprehensive bioinformatics. SCJD and normal samples were collected from GSE160208. Weighted gene co-expression network analysis (WGCNA) and Limma R package were used to obtain key genes, which were used for enrichment and immune cell infiltration analyses. Protein-protein interaction (PPI) network, cytoHubba, and machine learning were used to screen the central genes of SCJD. The chemicals related to hub genes were predicted and explored by molecular docking. 88 candidate genes were screened. Enrichment analysis showed they were mainly related to bacterial and viral infection and immune cell activation. Immune cell infiltration analysis suggested that immune cell activation and altered activity of the immune system are involved in the progression of SCJD. After identifying hub genes, KIT and SPP1 had higher diagnostic efficacy for SCJD (AUC > 0.9), so they were identified as central genes. The molecular docking results showed hub genes both docked well with Tretinoin. KIT, SPP1, and Tretinoin are essential in developing neuroinflammation in SCJD and may provide new ideas for diagnosing and treating SCJD.

Citing Articles

Neuroinflammatory fluid biomarkers in patients with Alzheimer's disease: a systematic literature review.

Heneka M, Gauthier S, Chandekar S, Hviid Hahn-Pedersen J, Bentsen M, Zetterberg H Mol Psychiatry. 2025; .

PMID: 40050444 DOI: 10.1038/s41380-025-02939-9.

New preclinical biomarkers for prion diseases in the cerebrospinal fluid proteome revealed by mass spectrometry.

Perez-Lazaro S, Barrio T, Bravo S, Sevilla E, Otero A, Chantada-Vazquez M Vet Q. 2024; 44(1):1-15.

PMID: 39520708 PMC: 11552261. DOI: 10.1080/01652176.2024.2424837.

Feng F, Chu Y, Yao Y, Xu B, Song Q Heliyon. 2024; 10(10):e31202.

PMID: 38803953 PMC: 11128934. DOI: 10.1016/j.heliyon.2024.e31202.

References

Zhao X, Zhao Y, Jiang Y, Zhang Q . Deciphering the endometrial immune landscape of RIF during the window of implantation from cellular senescence by integrated bioinformatics analysis and machine learning. Front Immunol. 2022; 13:952708. PMC: 9484583. DOI: 10.3389/fimmu.2022.952708. View

Diaz-Lucena D, Kruse N, Thune K, Schmitz M, Villar-Pique A, da Cunha J . TREM2 expression in the brain and biological fluids in prion diseases. Acta Neuropathol. 2021; 141(6):841-859. PMC: 8113222. DOI: 10.1007/s00401-021-02296-1. View

Houle B, Rochette-Egly C, BRADLEY W . Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells. Proc Natl Acad Sci U S A. 1993; 90(3):985-9. PMC: 45795. DOI: 10.1073/pnas.90.3.985. View

Rentsendorj A, Sheyn J, Fuchs D, Daley D, Salumbides B, Schubloom H . A novel role for osteopontin in macrophage-mediated amyloid-β clearance in Alzheimer's models. Brain Behav Immun. 2017; 67:163-180. PMC: 5865478. DOI: 10.1016/j.bbi.2017.08.019. View

Makarava N, Chang J, Molesworth K, Baskakov I . Region-specific glial homeostatic signature in prion diseases is replaced by a uniform neuroinflammation signature, common for brain regions and prion strains with different cell tropism. Neurobiol Dis. 2020; 137:104783. PMC: 7052953. DOI: 10.1016/j.nbd.2020.104783. View

Li M, Song S, Lippman S, Zhang X, Liu X, Lotan R . Induction of retinoic acid receptor-beta suppresses cyclooxygenase-2 expression in esophageal cancer cells. Oncogene. 2002; 21(3):411-8. DOI: 10.1038/sj.onc.1205106. View

Hong S, Beja-Glasser V, Nfonoyim B, Frouin A, Li S, Ramakrishnan S . Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016; 352(6286):712-716. PMC: 5094372. DOI: 10.1126/science.aad8373. View

Aguzzi A, Zhu C . Microglia in prion diseases. J Clin Invest. 2017; 127(9):3230-3239. PMC: 5669569. DOI: 10.1172/JCI90605. View

Hermann P, Appleby B, Brandel J, Caughey B, Collins S, Geschwind M . Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol. 2021; 20(3):235-246. PMC: 8285036. DOI: 10.1016/S1474-4422(20)30477-4. View

10.

Williams P, Tribble J, Pepper K, Cross S, Morgan B, Morgan J . Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma. Mol Neurodegener. 2016; 11:26. PMC: 4822272. DOI: 10.1186/s13024-016-0091-6. View

11.

Davis A, Wiegers T, Wiegers J, Johnson R, Sciaky D, Grondin C . Chemical-Induced Phenotypes at CTD Help Inform the Predisease State and Construct Adverse Outcome Pathways. Toxicol Sci. 2018; 165(1):145-156. PMC: 6111787. DOI: 10.1093/toxsci/kfy131. View

12.

Vasek M, Garber C, Dorsey D, Durrant D, Bollman B, Soung A . A complement-microglial axis drives synapse loss during virus-induced memory impairment. Nature. 2016; 534(7608):538-43. PMC: 5452615. DOI: 10.1038/nature18283. View

13.

Areskeviciute A, Litman T, Broholm H, Melchior L, Nielsen P, Green A . Regional Differences in Neuroinflammation-Associated Gene Expression in the Brain of Sporadic Creutzfeldt-Jakob Disease Patients. Int J Mol Sci. 2020; 22(1). PMC: 7795938. DOI: 10.3390/ijms22010140. View

14.

Benoit M, Hernandez M, Dinh M, Benavente F, Vasquez O, Tenner A . C1q-induced LRP1B and GPR6 proteins expressed early in Alzheimer disease mouse models, are essential for the C1q-mediated protection against amyloid-β neurotoxicity. J Biol Chem. 2012; 288(1):654-65. PMC: 3537064. DOI: 10.1074/jbc.M112.400168. View

15.

Eberhardt J, Santos-Martins D, Tillack A, Forli S . AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings. J Chem Inf Model. 2021; 61(8):3891-3898. PMC: 10683950. DOI: 10.1021/acs.jcim.1c00203. View

16.

Nguyen H, Kim M . The protective effects of curcumin on metabolic syndrome and its components: In-silico analysis for genes, transcription factors, and microRNAs involved. Arch Biochem Biophys. 2022; 727:109326. DOI: 10.1016/j.abb.2022.109326. View

17.

Zerr I, Kallenberg K, Summers D, Romero C, Taratuto A, Heinemann U . Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009; 132(Pt 10):2659-68. PMC: 2759336. DOI: 10.1093/brain/awp191. View

18.

Alawieh A, Langley E, Weber S, Adkins D, Tomlinson S . Identifying the Role of Complement in Triggering Neuroinflammation after Traumatic Brain Injury. J Neurosci. 2018; 38(10):2519-2532. PMC: 5858594. DOI: 10.1523/JNEUROSCI.2197-17.2018. View

19.

Llorens F, Thune K, Tahir W, Kanata E, Diaz-Lucena D, Xanthopoulos K . YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias. Mol Neurodegener. 2017; 12(1):83. PMC: 5681777. DOI: 10.1186/s13024-017-0226-4. View

20.

Xu X . Tumor-suppressive activity of retinoic acid receptor-beta in cancer. Cancer Lett. 2006; 253(1):14-24. PMC: 2562790. DOI: 10.1016/j.canlet.2006.11.019. View